EP Patent

EP0845265A1 — Mucosal preparation containing physiologically active peptide

Assigned to Hisamitsu Pharmaceutical Co Inc · Expires 1998-06-03 · 28y expired

What this patent protects

A preparation for transmucosal administration admixed with at least absorption promotor and vasodilator in physiologically active peptide is provided. Absorption of the physiologically active peptide can be increased by combining the peptide with absorption promotor and a compoun…

USPTO Abstract

A preparation for transmucosal administration admixed with at least absorption promotor and vasodilator in physiologically active peptide is provided. Absorption of the physiologically active peptide can be increased by combining the peptide with absorption promotor and a compound having vasodilating activity. Accordingly auto-administration can be performed by the patients without pain of injection. It is useful for long term administration of physiologically active peptide. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
EP0845265A1
Jurisdiction
EP
Classification
—
Expires
1998-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Hisamitsu Pharmaceutical Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.